tradingkey.logo
tradingkey.logo
Suchen

Inogen Inc

INGN
Zur Watchlist hinzufügen
6.300USD
-0.080-1.25%
Handelsschluss 05/18, 16:00ETKurse um 15 Minuten verzögert
170.57MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Inogen Inc Unternehmen

Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.

Inogen Inc Informationen

BörsenkürzelINGN
Name des UnternehmensInogen Inc
IPO-datumFeb 14, 2014
CEOSmith (Kevin R. M)
Anzahl der mitarbeiter766
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 14
Addresse859 Ward Drive
StadtGOLETA
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl93111
Telefon18055620500
Websitehttps://www.inogen.com/
BörsenkürzelINGN
IPO-datumFeb 14, 2014
CEOSmith (Kevin R. M)

Führungskräfte von Inogen Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Michael J. Bourque
Mr. Michael J. Bourque
Chief Financial Officer, Executive Vice President, Corporate Treasurer
Chief Financial Officer, Executive Vice President, Corporate Treasurer
94.60K
--
Mr. Kevin M. King
Mr. Kevin M. King
Independent Director
Independent Director
46.27K
-18.89%
Mr. Glenn S. Boehnlein, CPA
Mr. Glenn S. Boehnlein, CPA
Independent Director
Independent Director
46.27K
-18.89%
Mr. Gregoire Ramade
Mr. Gregoire Ramade
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
44.23K
--
Ms. Mira Sahney
Ms. Mira Sahney
Independent Director
Independent Director
9.11K
-235.95%
Ms. Heather D. Rider
Ms. Heather D. Rider
Independent Director
Independent Director
--
--
Ms. Elizabeth (Beth) Mora, CPA
Ms. Elizabeth (Beth) Mora, CPA
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Mary Katherine (Kay) Ladone
Ms. Mary Katherine (Kay) Ladone
Independent Director
Independent Director
--
--
Mr. Ryan Peterson
Mr. Ryan Peterson
Associate Director - Investor Relations
Associate Director - Investor Relations
--
--
Mr. Kevin R. M. Smith
Mr. Kevin R. M. Smith
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Michael J. Bourque
Mr. Michael J. Bourque
Chief Financial Officer, Executive Vice President, Corporate Treasurer
Chief Financial Officer, Executive Vice President, Corporate Treasurer
94.60K
--
Mr. Kevin M. King
Mr. Kevin M. King
Independent Director
Independent Director
46.27K
-18.89%
Mr. Glenn S. Boehnlein, CPA
Mr. Glenn S. Boehnlein, CPA
Independent Director
Independent Director
46.27K
-18.89%
Mr. Gregoire Ramade
Mr. Gregoire Ramade
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
44.23K
--
Ms. Mira Sahney
Ms. Mira Sahney
Independent Director
Independent Director
9.11K
-235.95%
Ms. Heather D. Rider
Ms. Heather D. Rider
Independent Director
Independent Director
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Mon, Apr 6
Währung: USDAktualisiert: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
U.S. revenue
209.84M
60.18%
Non-U.S. revenue
138.83M
39.82%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Thu, May 14
Aktualisiert: Thu, May 14
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
9.70%
BlackRock Institutional Trust Company, N.A.
5.59%
Armistice Capital LLC
4.67%
Acadian Asset Management LLC
4.00%
Vanguard Capital Management, LLC
3.83%
Andere
72.21%
Aktionäre
Aktionäre
Anteil
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
9.70%
BlackRock Institutional Trust Company, N.A.
5.59%
Armistice Capital LLC
4.67%
Acadian Asset Management LLC
4.00%
Vanguard Capital Management, LLC
3.83%
Andere
72.21%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
27.07%
Investment Advisor/Hedge Fund
24.09%
Hedge Fund
22.30%
Corporation
9.70%
Research Firm
2.60%
Individual Investor
2.19%
Family Office
0.81%
Bank and Trust
0.23%
Pension Fund
0.23%
Andere
10.77%

Institutionelle Beteiligung

Aktualisiert: Wed, Apr 1
Aktualisiert: Wed, Apr 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q1
294
20.74M
75.89%
-3.29M
2025Q4
304
19.74M
72.70%
-4.65M
2025Q3
308
19.98M
73.65%
-4.59M
2025Q2
330
22.77M
84.68%
-2.73M
2025Q1
372
22.71M
84.47%
-2.93M
2024Q4
375
21.79M
82.19%
-5.25M
2024Q3
367
21.78M
91.28%
-6.90M
2024Q2
360
23.19M
97.91%
-6.59M
2024Q1
364
22.78M
97.44%
-4.92M
2023Q4
369
22.26M
95.31%
-4.56M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
2.63M
9.64%
+2.63M
--
Feb 21, 2025
BlackRock Institutional Trust Company, N.A.
1.51M
5.56%
+21.90K
+1.47%
Dec 31, 2025
Armistice Capital LLC
1.26M
4.64%
+400.00K
+46.30%
Dec 31, 2025
Acadian Asset Management LLC
1.08M
3.98%
+16.40K
+1.54%
Dec 31, 2025
Camber Capital Management LP
975.00K
3.58%
--
--
Jun 30, 2025
Columbia Threadneedle Investments (US)
860.55K
3.16%
+7.82K
+0.92%
Dec 31, 2025
Dafna Capital Management, LLC
827.07K
3.04%
+221.45K
+36.56%
Dec 31, 2025
Geode Capital Management, L.L.C.
599.41K
2.2%
-9.88K
-1.62%
Dec 31, 2025
Renaissance Technologies LLC
583.00K
2.14%
-8.40K
-1.42%
Dec 31, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Cultivar ETF
0.59%
Invesco NASDAQ Future Gen 200 ETF
0.55%
Federated Hermes MDT Small Cap Core ETF
0.25%
JPMorgan Fundamental Data Science Small Core ETF
0.11%
iShares Micro-Cap ETF
0.04%
Avantis US Small Cap Equity ETF
0.02%
Proshares Ultra Russell 2000
0.01%
ProShares Hedge Replication ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Global X Russell 2000 ETF
0.01%
Mehr Anzeigen
Cultivar ETF
Anteil0.59%
Invesco NASDAQ Future Gen 200 ETF
Anteil0.55%
Federated Hermes MDT Small Cap Core ETF
Anteil0.25%
JPMorgan Fundamental Data Science Small Core ETF
Anteil0.11%
iShares Micro-Cap ETF
Anteil0.04%
Avantis US Small Cap Equity ETF
Anteil0.02%
Proshares Ultra Russell 2000
Anteil0.01%
ProShares Hedge Replication ETF
Anteil0.01%
ProShares UltraPro Russell2000
Anteil0.01%
Global X Russell 2000 ETF
Anteil0.01%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI